Akadeum Life Sciences just landed a six-figure seed capital round. The $150,000 raise was led by Ann Abror-based venture capital firm Michigan eLab.
"They are wicked smart entrepreneurs doing something really hard that will have a big impact on the world," says Doug Neal, managing director of
Michigan eLab. "Those three criteria are really important to us."
Akadeum Life Sciences is developing a platform that helps researchers prepare samples faster and more efficiently. It uses buoyant beads to improve cell isolation, allowing the targeting of cells in complex solutions using surface antigens.
The technology was spun out of the University of Michigan and the two-person startup leveraged a number of local entrepreneurial resources along the way, including U-M's
I-Corps program and
Invest Detroit. It is currently sharing space at
Menlo Innovations office in downtown Ann Arbor, receiving mentorship from the company’s principals, like
Richard Sheridan.
"We like their approach to solving problems and making products, which is customer-oriented," says Brandon McNaughton, co-founder & CEO of Akadeum Life Sciences.
The 9-month-old startup is rare in that already has customers. Eight researchers working on cancer research are paying for the technology and another half a dozen potential customers are in the pipeline.
"We want this in as many hands as we can possible get," says John Younger, co-founder & CSO of Akadeum Life Sciences.
Source: Brandon McNaughton, co-founder & CEO of Akadeum Life Sciences; John Younger, co-founder & CSO of Akadeum Life Sciences; Doug Neal, managing director of Michigan eLab
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.